UNSPSC 51291504: Cimoxatone

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51291504

Definition

This classification denotes a monoamine oxidase inhibitor with the molecular formula C19H18N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6FT1QJ7VL, chemically known as benzonitrile, 3-((4-(5-(methoxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)- but generally known as cimoxatone, which bears US NIH Compound Identifier 52542. European Medicines Agency schedules Cimoxatone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06281MIG.

Read the full definition

The term CIMOXATONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). CIMOXATONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cimoxatone under HS 29349990 and SITC 51579. As of Q4 2014, CIMOXATONE remains the US FDA Preferred Term for this commodity. Cimoxatone bears US NLM identifiers UMLS ID C0109794 and NCI Concept Code C90879. SMILES: O1C(CN(c2ccc(OCc3cc(ccc3)C#N)cc2)C1=O)COC.

About UNSPSC 51291504

UNSPSC 51291504 Cimoxatone, a Commodity code, encompasses pharmaceutical and chemical compounds procured by state and local health and emergency-response agencies. Recent state and local activity under this code reflects purchasing of naloxone and related drug-deactivation or emergency-response pharmaceutical systems rather than cimoxatone specifically, indicating that the code captures a broader family of emergency medical and harm-reduction products in active procurement. State and local buyers under this code include county health departments and public health authorities managing community health initiatives, substance-abuse response programs, and emergency medical supply chains. The procurement activity targets operational supply chains with defined annual volumes and recurring delivery schedules, reflecting established health-system demand rather than one-time capital procurement.

Seminole County, Florida, represents the documented recent activity under this code. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking competitive bids for 1,900 units of naloxone and 800 safe drug deactivation systems annually through a two-year contract with one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid deadline was July 26, 2023, at 2:00 pm; vendors were required to submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in pricing, provide unit costs for each line item, and comply with drug-free workplace certification, E-Verify, and applicable federal compliance requirements, including potential FEMA funding stipulations. The contract includes a three-month probationary period and standard insurance requirements covering workers' compensation, commercial general liability, and professional liability.

Quick answers

What is UNSPSC 51291504?

UNSPSC 51291504 is Cimoxatone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51291504?

UNSPSC 51291504 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51291504

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code